Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022
MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the...
Staff
Alignment Healthcare Welcomes Randall Fitzpatrick, Formerly of Optum, as Senior Vice President of Product
ORANGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that...
Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2
Strategic collaboration with Medtronic to develop BackBeat Cardiac Neuromodulation Therapy™ as potential integrated hypertension treatment for cardiac pacemaker...
89bio Announces Closing of its Upsized $94.5 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the...
Ayala Pharmaceuticals Announces Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102 in Desmoid Tumors
- Tumor shrinking observed in substantially all patients who were evaluable at 16 weeks - - Favorable safety results observed:...
Eloxx Pharmaceuticals Announces Changes to Board of Directors
Lindsay Androski, JD, MBA brings significant experience growing biotech companies through her roles as an executive at Roivant Social Ventures...
Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN)
SEATTLE, July 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program – Ketamine-Assisted Therapy for Alcohol Use Disorder
Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase IIIToronto, Ontario--(Newsfile Corp. - July...
Perspectum Announces American Medical Association (AMA) Issues Two Unique Category III CPT® Codes Priced Appropriately by the Centers for Medicare & Medicaid Services (CMS) for Noninvasive Biliary Anatomy Assessment With MRCP+
DALLAS--(BUSINESS WIRE)--#Healthcare--The American Medical Association (AMA) has issued two unique Category III Current Procedural Terminology (CPT®) codes for Quantitative Magnetic...
Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients
New Study Evaluates Masimo SafetyNet in Helping Patients Recover at Home IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings...
Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of Sales, North America
Bringing More Than 20 Years of Experience to Sonendo, Lindberg Will Focus on Accelerating Sales Growth LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo,...
Defence’s Accum(TM) with Antibody Drug Conjugates (ADC) in Development Against Cancer
Vancouver, British Columbia--(Newsfile Corp. - July 5, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
AlzeCure Gets Abstract on New Clinical Study Data with NeuroRestore Accepted at the Alzheimer’s Conference AAIC
STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...
Pharnext Appoints Antoine Gravelle as General Counsel
PARIS, FRANCE / ACCESSWIRE / July 5, 2022 / Pharnext SA (FR0011191287-ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company...
Evotec Completes Acquisition of Rigenerand
AS "EVOTEC CELL ACCELERATOR", THE HIGH-QUALITY CGMP CELL THERAPY MANUFACTURING SITE ADDS CAPACITY AND CAPABILITYEVOTEC'S EVO CELLS PLATFORM INTEGRATES INNOVATIVE...
LevelJump Closes Private Placement Raising Gross Proceeds of over $877,000
Toronto, Ontario--(Newsfile Corp. - July 4, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
wellteq Digital Health Inc. Announces Director Resignation
Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - wellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or...
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
Company also provides bi-weekly MCTO status updateVancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE:...
Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), announced...
Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk
GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a...